Doyle Janeen Noel bought JANX
January 2, 2026 · Form 4 insider transaction
Doyle Janeen Noel bought 126,000 shares of Janux Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
126,000
Price
$0.00
Total value
N/A
InsiderDoyle Janeen Noel
RoleOfficer
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 2, 2026
Shares owned after126,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.